STATE BILLNY A 1248ENGROSSED

Prohibits the knowing sale, offer for sale, or delivery of xylazine to persons under the age of 21 and without proof of the intended use for institutional, veterinary, or scientific purposes.

State of New York

Status: Engrossed; Passed its first chamber
Status date: May 21, 2025; 540 days ago
Current chamber: Senate
Session: 2025-2026 Regular Session

NY A 1248 · EngrossedMay 21

Follow the legislation that affects what you sell.

Get started free

Free account · 30-second setup · No credit card

Prefer ChatGPT or Claude? Ask Civic IQ about this bill →

What it means for vendors

Civic IQ reads each bill for what it would fund, require or change for the agencies that buy.

What this bill would fund or requireThe spending and mandates in the bill, in plain languageTop matches free Why it matters for what you sellMatched to your products, with how to open the conversationTop matches free 1 signal from this bill in Civic IQSee them free →

Bill details

Last action: REFERRED TO CONSUMER PROTECTION · Mar 10, 2026
Pending committee: Consumer Affairs and Protection

Bill history

Newest first.

Mar 10, 2026REFERRED TO CONSUMER PROTECTIONSenate

Mar 10, 2026delivered to senateAssembly

Mar 10, 2026passed assemblyAssembly

Jan 12, 2026amended on third reading (t) 1248cAssembly

Jan 7, 2026ordered to third reading cal.44Assembly

Jan 7, 2026RETURNED TO ASSEMBLYSenate

Jan 7, 2026DIED IN SENATESenate

May 27, 2025RECOMMITTED TO CONSUMER PROTECTIONSenate

Show 18 earlier actions

May 27, 2025returned to senateAssembly

May 27, 2025repassed assemblyAssembly

May 22, 2025amended on third reading 1248bAssembly

May 22, 2025vote reconsidered - restored to third readingAssembly

May 22, 2025RETURNED TO ASSEMBLYSenate

May 22, 2025recalled from senateAssembly

May 21, 2025REFERRED TO COMMERCE, ECONOMIC DEVELOPMENT AND SMALL BUSINESSSenate

May 21, 2025delivered to senateAssembly

May 21, 2025passed assemblyAssembly

May 21, 2025ordered to third reading rules cal.202Assembly

May 21, 2025rules report cal.202Assembly

May 21, 2025reportedAssembly

May 20, 2025reported referred to rulesAssembly

Apr 21, 2025print number 1248aAssembly

Apr 21, 2025amend (t) and recommit to ways and meansAssembly

Apr 2, 2025reported referred to ways and meansAssembly

Mar 25, 2025reported referred to codesAssembly

Jan 9, 2025referred to consumer affairs and protectionAssembly

Recorded votes

Assembly Consumer Affairs And Protection Committee: Favorable refer to committee CodesMar 25, 2025 · Assembly · 15 yea · 0 nayPassed

Assembly Codes Committee: Favorable refer to committee Ways and MeansApr 2, 2025 · Assembly · 20 yea · 0 nayPassed

Assembly Ways And Means Committee: Favorable refer to committee RulesMay 20, 2025 · Assembly · 35 yea · 0 nayPassed

Assembly Rules Committee: FavorableMay 21, 2025 · Assembly · 29 yea · 0 nayPassed

Assembly Floor Vote - Final PassageMay 21, 2025 · Assembly · 144 yea · 0 nayPassed

Read the bill at the source

This page follows the bill as the legislature records it. For the bill's full text and the official record, use the legislature's own site.

View on the legislature's site View on LegiScan

Bill data from LegiScan, licensed under CC BY 4.0.

Work in government? Get Civic IQ free →

State of New York profile →

Prohibits the knowing sale, offer for sale, or delivery of xylazine to persons under the age of 21 and without proof of the intended use for institutional, veterinary, or scientific purposes.

What it means for vendors

Bill details

Sponsors

Bill history

Recorded votes

Read the bill at the source

Start finding government buyers today.
It's free.

Prohibits the knowing sale, offer for sale, or delivery of xylazine to persons under the age of 21 and without proof of the intended use for institutional, veterinary, or scientific purposes.

What it means for vendors

Bill details

Sponsors

Bill history

Recorded votes

Read the bill at the source

Start finding government buyers today.It's free.

Start finding government buyers today.
It's free.